The Korean Journal of Nuclear Medicine (대한핵의학회지)

The Korean Society of Nuclear Medicine (대한핵의학회)
권호 표지

Fibrous Dysplasia Associated with Primary Hyperparathyroidism Absent of McCune-Albright Syndrome: Tc-99m MIBI and Tc-99m MDP Findings

  • Kim, Seong-Jang (Department of Nuclear Medicine, College of Medicine, Pusan National University) ;
  • Seok, Ju-Won (Department of Nuclear Medicine, College of Medicine, Pusan National University) ;
  • Kim, In-Ju (Department of Nuclear Medicine, College of Medicine, Pusan National University) ;
  • Kim, Yong-Ki (Department of Nuclear Medicine, College of Medicine, Pusan National University) ;
  • Kim, Dong-Soo (Department of Nuclear Medicine, College of Medicine, Pusan National University)
  • Published : 2003.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

섬유성 골이형성증은 비정상적인 섬유성 골조직으로 대체되며 느리게 진행하는 골병변이다. 섬유성 골이형성증과 부갑상선기능항진증은 흔하게 관찰되는 질환이나 McCune-Albright 증후군 없이 일차성 부갑상선기능항진증에 동반된 섬유성 골 이형성증은 거의 보고된바가 없다. Tc-99m MDP 골스캔이 섬유성 골이형성증의 진단에 유용하다고 알려져 있으나, Tc-99m MIBI 영상은 아직 보고된 바가 없다. 저자들은 McCune-Albright 증후군이 없이 부갑상선기능항진증에 동반된 섬유성 골 이형성증의 Tc-99m MIBI 스캔과 Tc-99m MDP 골스캔의 영상을 비교하였다. Tc-99m MDP 골스캔상 병변 부위에서 증가된 섭취 소견을 보였으며, Tc-99m MIBI 조기영상에서도 동일한 위치에서 섭취증가가 관찰되었다. 2시간 지연 Tc-99m MIBI 영상에서는 Tc-99m MIBI의 섭취가 배출되는 소견을 보였다. 섬유성 골이형성증 병변에서 Tc-99m MIBI 스캔이 유용할 것이라고 생각하며, 섬유성 골이형성증 병변에서 Tc-99m MIBI의 섭취를 증가시키는 인자에 대한 더 많은 연구가 필요할 것으로 생각한다.

Keywords

References

  1. Albright F, Butler AM, Hampton AO. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females. N Engl J Med 1937;216:727-47
  2. Hammami MM, al-Zahrani A, Butt A, Veneer LJ, Hussain SS. Primary hyperparathyroidism associated polyostotic fibrous dysplasia: absence of McCune-Albright syndrome mutations. J endocrinol Invest 1997;20:552-8
  3. Rosen IB, Palmer JA Fibroosseous tumors of the facial skeleltonin association with primary hyperparathyroidism: an endocrine syndrome or coincidence ? Am J Surg 1981;142:494-8
  4. Caudill R, Saltzman O, Gaum S, Granite E. Possible relationship of primary hyperparathyroidism and fibrous dysplasia: report of case. J Oral Surg 1977;35:483-90
  5. Kim SJ, Seok JW, Kim U, Kim YK Tc-99m MIBI scintigraphy in a patient with primary and metastatic malignant melanoma. Clin Nucl Med 2002;27:351-3
  6. Kim SJ, Kim U, Kim YK Tc-99m Milll, Tc-99m tetrofosmin, and Tc-99m (V) DMSA accumulation in recurrent malignant thymoma. Clin Nucl Med 2002; 27:30-3
  7. Kim SJ, Kim U, Kim YK, Bae YT. Teclmetium-99m tetrofosmin scintimammography in suspected breast caneer patients: a comparison with technetium-99m MIBI. Med Princ Prac 2000;9:282-9
  8. Dominguez R, Saucedo J, Fenstermacher M. MRI findings in osteofibrous dysplasia. Magn Reson Imag 1989;7:567-70
  9. Casselman JW, Jonge ID, Neyt L, De Clercg C, D Hont G. MRI in craniofacial fibrous dysplasia. Neuroradiol 1993;35:234-7
  10. Jee WH, Choi KH, Choe BY, Park JM, Shinn KS. Fibrous dysplasia: MR imagingcharacteristics with radiopathologic correlation. Am J Roentgenol 1996; 167:1523-7
  11. Daffner RH, Kirks DR, Gehweiler JA, Heaston DK. Computed tomography of fibrous dysplasia. Am J Radiol 1982; 139:943-8
  12. Machida K, Makita K, Nishikawa J, Ohtake T, Iio M Scintigraphic manifestation of fibrous dysplasia. Clin Nucl Med 1986;11:426-9
  13. Jimenez CE, Moreno AJ, Pacheco EJ, Carpenter AL. SPECT imaging in a patient with monostotic rib fibrous dysplasia. Clin Nucl Med 1996;21:491-3
  14. Di Leo C, Ardemagni A, Bestetti A, Tagliabue L, Del Sole A, Conte A, et al. A rare case of polyostotic fibrous dysplasia assessed by bone scintigraphy with Tc-99m methylene diphosphonate (MOP). Nuklearmedizin 1999:38: 169-71
  15. Hardoff R, Eisenberg D, Gross B. Bone scintigraphy in polyostotic fibrous dysplasia resembling multiple bone metastases. Clin Nucl Med 1989;14:928-9
  16. Johns WD, Gupta SM, Kayani N. Scintigraphic evaluation of polyostotic fibrous dysplasia. Clin Nucl Med 1987;12:627-31
  17. Feldman F. Tuberous sclerosis, neurofibromatosis, and fibrous dysplasia. In: Resnick D, editors. Diagnosis of bone andJoint disorders. 3rd ed. Philadelphia: Saunders; 1995. p. 4379-92
  18. Mauras N, Bizzard RM. The McCune-Albright syndrome. Acta Endocrinol 1986;279:207-17
  19. Fraser WD, Walsh CA, Birch MA, Durham B, Dillon JP, McGreavy D, et al. Parathyroid hormone related protein in the etiology of fibrous dysplasia of bone in the McCune-Albright syndrome. Clin Endocrinol 2000;53: 621-8
  20. Dierks EJ, Caudill RJ, O'Leary JD. Surgial recountering of panfacial fibro-osseous deformity. J Oral Surg 1979;37:682-7
  21. Han JM, Ryu JS, Shin MJ, Kang GH, Lee HK. Fibrous dysplasia with barely increased uptake on bone scan: a case report. Clin Nucl Med 2000;25:785-8
  22. Creagh MF, Nunan TO. Positive gallimn-67 citrate uptake in a patient with polyostotic fibrous dysplasia. Clin Nucl MOO 1988;13:241-2
  23. Chen CC, Czerwiec FS, Feuillan PP. Visualization of fibrous dysplasia during somatostatin receptor scintigraphy. J Nucl MOO 1998;39:238-40
  24. Swyer AJ, Palestro CJ, Kim CC, Goldsmith SJ. Appearance of fibrous dysplasia on In-111l labeled leukocyte scintigraphy. Clin Nucl MOO 1991;16:133-5
  25. Pai M, Park CH, Kim BS, Chung YS, Park HB. Multiple brown tumors in parathyroid carcinoma mimicking metastatic bone disease. Clin Nucl MOO 1997;22:691-4
  26. Fujii H, Nakamura K, Kubo A. Enomoto K, IkedaT, Kubota T, et al. Preoperative evaluation of the chemosensitivity of breast cancer by meaus of double phase Tc-99m MIBI scintimannnography. Ann Nucl MOO 1998;12:307-12
  27. Yoon JH, Bom HS, Song HC, Lee JH, Jaegal YJ. Double phase Tc-99m sestannbi scintimannnography to assess angiogenesis andp-giycoprotein expression in patientswith untreated breast cancer. Clin Nucl MOO 1999;24:314-8